Screening brain MRI in advanced lung cancer patients
Part of Brain & nervous system, Cancer clinical trials.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV metastatic non-small cell lung cancer confirmed by pathology (tissue or fluid samples).
- Your cancer is not expected to be cured with standard curative treatment.
- You are well enough for whole-body (systemic) cancer treatment (an overall health score of 0–2).
- Your lung cancer specialist does not think you currently have symptoms of brain problems.
- You have not started or received treatments specifically for stage IV disease before joining the trial.
- You do not have a gene change (like EGFR, ALK, ROS1, RET, MET, or BRAF) that already has an approved targeted treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether doing scheduled brain MRI scans can lower the chance that lung cancer later causes symptomatic brain metastases (tumors that cause symptoms in the brain). If you’re eligible, you’ll get brain MRI surveillance at a specific time after starting radiation.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
Hear when a new Non Small Cell Lung Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.